LL-37 (Cathelicidin)
LL-37 (Cathelicidin) is a healing & repair peptide used in evidence-based, physician-supervised protocols. Use for chronic sinusitis, biofilm-related infections, wound healing, or immune optimization.
What is LL-37 (Cathelicidin)?
Human cathelicidin antimicrobial peptide. Broad-spectrum bactericidal (membrane disruption), antiviral, antifungal. Also stimulates wound healing, angiogenesis, and modulates innate immunity.
Uses & clinical decision logic
Use for chronic sinusitis, biofilm-related infections, wound healing, or immune optimization. Intranasal formulation for chronic sinusitis; topical (0.1-1%) for wound healing.
LL-37 (Cathelicidin) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 2mL | 100-500mcg | 4-20 units | 3x/week | SubQ/IM |
Safety & contraindications
Can cause injection site discomfort at high doses; start low and titrate. Monitor for allergic reactions.
Stacking & combinations
Combines with KPV and TA-1 for comprehensive immune stack; compatible with BPC-157.
Related peptides
Frequently asked questions
What is LL-37 (Cathelicidin) used for?
Use for chronic sinusitis, biofilm-related infections, wound healing, or immune optimization. Intranasal formulation for chronic sinusitis; topical (0.1-1%) for wound healing.
What is the typical LL-37 (Cathelicidin) dosage?
Common dosing ranges from 100-500mcg (3x/week, SubQ/IM). Exact dosing is individualized and set by a licensed physician.
How is LL-37 (Cathelicidin) administered?
LL-37 (Cathelicidin) is typically administered via SubQ/IM.
What are the contraindications for LL-37 (Cathelicidin)?
Can cause injection site discomfort at high doses; start low and titrate. Monitor for allergic reactions.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.